Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKurszieleVergleichProfilKnock-OutsSenden
OrderbuchRealtime StuttgartFundamentalanalyseRatingInsidertradesFondsInvestmentreport
HistorischRealtime PushmyNews im ForumAnleihen
Kaufen
Verkaufen
  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
13.05.15
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody (Businesswire)
11.05.15
Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company (Businesswire)
24.04.15
Pfizer kündigt 306. Quartalsdividende in Folge an (MyDividends)
20.04.15
Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer (Businesswire)
07.04.15
Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib) (Businesswire)
16.12.14
Pfizer mit höherer Dividende (MyDividends)
24.10.14
Pfizer zahlt 304. Quartalsdividende in Folge (MyDividends)
07.08.14
European Medicines Agency Accepts Application Seeking New Indication For Prevenar 13®1 For Prevention Of Pneumococcal Pneumonia In Adults (Businesswire)
30.07.14
Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines (Businesswire)
27.06.14
Pfizer zahlt 303. Quartalsdividende in Folge (MyDividends)
18.06.14
Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration (Businesswire)
23.05.14
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis (Businesswire)
02.05.14
Pfizer Sends Letter to Rt Hon David Cameron MP Regarding Commitments If Proposed Combination with AstraZeneca is Completed (Businesswire)
02.05.14
Pfizer Confirms Delivery of Increased Proposal to AstraZeneca (Businesswire)
17.12.13
Pfizer zahlt 301. Quartalsdividende in Folge (MyDividends)
02.12.13
Pfizer Acquires Polocard, Poland’s Leading Over-The-Counter Heart Attack Prevention Brand (Businesswire)
25.10.13
Pfizer wird 24 Cents Dividende auszahlen (MyDividends)
25.07.13
CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer’s XELJANZ® (tofacitinib citrate) (Businesswire)
13.05.13
Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting (Businesswire)
10.03.13
New trial results support treatment with Inspra (eplerenone) within first 24 hours of symptoms, in addition to standard therapy, in patients with acute STEMI without heart failure. (Businesswire)
11.10.12
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02: (Businesswire)
10.10.12
New Report Reveals Programs That Promote Healthy Ageing Can Help Reduce Rising Health Costs1 (Businesswire)
21.09.12
ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation (Businesswire)
21.09.12
ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation (Businesswire)
04.09.12
Pfizer Receives EU Marketing Authorization for INLYTA® (Axitinib) (Businesswire)
15.08.12
Pfizer Commences Consent Solicitation for Amendments to Pharmacia Indentures (Businesswire)
10.08.12
Pfizer Reports Results From Phase 3 Study Of Torisel (temsirolimus) In Combination With Bevacizumab In Advanced Renal Cell Carcinoma (RCC) (Businesswire)
06.08.12
Summertime Shines a Light on the Need for Vitamin D (Businesswire)
31.07.12
Pfizer Reports Second-Quarter 2012 Results (Businesswire)
19.07.12
Pfizer and Northwestern University Win LYRICA® Patent Case in Delaware District Court (Businesswire)
28.06.12
Pfizer Declares A 22-Cent Third-Quarter 2012 Dividend (Businesswire)
26.06.12
Pfizer Invites Public to View and Listen to Webcast of July 31 Conference Call with Analysts (Businesswire)
21.06.12
FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review (Businesswire)
20.06.12
Pfizer Statement Regarding Prevnar 13® Receiving ACIP Recommendation for Prevention of Pneumococcal Disease in Adults With Immunocompromising Conditions (Businesswire)
19.06.12
Pfizer Announces Positive Results From Phase 3 Study PROFILE 1007 Evaluating XALKORI® (crizotinib) In Previously Treated Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (Businesswire)
18.06.12
FDA Issues Complete Response Letter For Pfizer’s Tafamidis Meglumine New Drug Application (Businesswire)
18.06.12
Have Americans Reached a New Era of Optimism about Aging? (Businesswire)
07.06.12
Pfizer Provides Update On Animal Health Strategic Alternatives Review Process (Businesswire)
25.05.12
Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU (Businesswire)
23.05.12
Pfizer Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units (Businesswire)
Seite: 123

Pfizer News

Pfizer News: auf dieser Seite finden Sie alle Pfizer News und Nachrichten zur Pfizer Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pfizer News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pfizer News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.